These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35903011)

  • 41. Interventions for the management of malignant pleural effusions: a network meta-analysis.
    Dipper A; Jones HE; Bhatnagar R; Preston NJ; Maskell N; Clive AO
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010529. PubMed ID: 32315458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials.
    Kong FY; Tabrizi SN; Law M; Vodstrcil LA; Chen M; Fairley CK; Guy R; Bradshaw C; Hocking JS
    Clin Infect Dis; 2014 Jul; 59(2):193-205. PubMed ID: 24729507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral vs. parenteral antibiotic therapy in adult patients with community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials.
    Teng GL; Chi JY; Zhang HM; Li XP; Jin F
    J Glob Antimicrob Resist; 2023 Mar; 32():88-97. PubMed ID: 36669558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of β-Lactam Plus Macrolide Versus Fluoroquinolone on 30-Day Readmissions for Community-Acquired Pneumonia.
    Gilbert TT; Arfstrom RJ; Mihalovic SW; Dababneh AS; Varatharaj Palraj BR; Dierkhising RA; Mara KC; Lessard SR
    Am J Ther; 2020; 27(2):e177-e182. PubMed ID: 30418221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database.
    Lee MG; Lee SH; Chang SS; Chan YL; Pang L; Hsu SM; Lee CC
    Medicine (Baltimore); 2015 Sep; 94(39):e1662. PubMed ID: 26426664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical efficacy and safety of moxifloxacin versus levofloxacin plus metronidazole for community-acquired pneumonia with aspiration factors.
    Sun T; Sun L; Wang R; Ren X; Sui DJ; Pu C; Ren Y; Liu Y; Yang Z; Li F
    Chin Med J (Engl); 2014; 127(7):1201-5. PubMed ID: 24709166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis.
    Sligl WI; Asadi L; Eurich DT; Tjosvold L; Marrie TJ; Majumdar SR
    Crit Care Med; 2014 Feb; 42(2):420-32. PubMed ID: 24158175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Shorter versus longer duration of Amoxicillin-based treatment for pediatric patients with community-acquired pneumonia: a systematic review and meta-analysis.
    R Marques I; P Calvi I; A Cruz S; M F Sanchez L; F Baroni I; Oommen C; H Padrao EM; C Mari P
    Eur J Pediatr; 2022 Nov; 181(11):3795-3804. PubMed ID: 36066660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
    Goldenberg JZ; Yap C; Lytvyn L; Lo CK; Beardsley J; Mertz D; Johnston BC
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD006095. PubMed ID: 29257353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.
    Lode H; File TM; Mandell L; Ball P; Pypstra R; Thomas M;
    Clin Ther; 2002 Nov; 24(11):1915-36. PubMed ID: 12501883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis and management of community-acquired pneumonia in adults.
    Watkins RR; Lemonovich TL
    Am Fam Physician; 2011 Jun; 83(11):1299-306. PubMed ID: 21661712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive
    Ha SG; Oh KJ; Ko KP; Sun YH; Ryoo E; Tchah H; Jeon IS; Kim HJ; Ahn JM; Cho HK
    J Korean Med Sci; 2018 Oct; 33(43):e268. PubMed ID: 30344461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Update on the role of levofloxacin in the management of acute community-acquired pneumonia].
    Bru JP
    Presse Med; 2002 Jun; 31(21 Pt 2):S19-22. PubMed ID: 12148386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimal pharmacological therapy for community-acquired pneumonia: the role of dual antibacterial therapy.
    Epstein BJ; Gums JG
    Drugs; 2005; 65(14):1949-71. PubMed ID: 16162020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ceftriaxone combination therapy versus respiratory fluoroquinolone monotherapy for community-acquired pneumonia: A meta-analysis.
    Zhang YQ; Zou SL; Zhao H; Zhang MM; Han CL
    Am J Emerg Med; 2018 Oct; 36(10):1759-1765. PubMed ID: 29499898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
    Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
    Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotics for secondary prevention of coronary heart disease.
    Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 13--Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents.
    Roig J; Casal J; Gispert P; Gea E
    Med Mal Infect; 2006; 36(11-12):680-9. PubMed ID: 17095177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systematic review and meta-analysis of the safety of erythromycin compared to clarithromycin in adults and adolescents with pneumonia.
    Eljaaly K; Botaish A; Bahobail F; Almehmadi M; Assabban Z; Thabit AK; Alraddadi B; Aljabri A; Alqahtani N; Aseeri MA; Hashim A; Torres A
    J Chemother; 2020 Feb; 32(1):1-6. PubMed ID: 31650904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of community-acquired pneumonia with moxifloxacin: a meta-analysis of randomized controlled trials.
    Yuan X; Liang BB; Wang R; Liu YN; Sun CG; Cai Y; Yu XH; Bai N; Zhao TM; Cui JC; Chen LA
    J Chemother; 2012 Oct; 24(5):257-67. PubMed ID: 23182045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.